The buzz around artificial intelligence may have quietened after a volatile week for some of the sector's biggest names, but Morgan Stanley continues...
The biopharmaceutical sector is anticipated to supply a protected haven from macroeconomic and earnings issues forward of ultimate quarterly outcomes from corporations, in...